Sabrina Correa da Costa, M.D.

  1. Addiction specialist
  2. Psychiatrist
  1. Oesterle TS, Bormann NL, Al-Soleiti M, Kung S, Singh B, McGinnis MT, Correa da Costa S, Rummans T, Chauhan M, Rojas Cabrera JM, Vettleson-Trutza SA, Scheitler KM, Shin H, Lee KH, Gold MS. Invasive and Non-Invasive Neuromodulation for the Treatment of Substance Use Disorders: A Review of Reviews. Brain Sci. 2025 Jul 6; 15 (7) Epub 2025 July 06
    View PubMed
  2. da Costa, Sabrina Correa, Ghafouri, Mohammad, Jorandby, Lantie E., Rummans, Teresa A., Gold, Mark S.. Buprenorphine: New Challenges and Opportunities Current Addiction Reports. 2025.
  3. Ghafouri M, Correa da Costa S, Zare Dehnavi A, Gold MS, Rummans TA. Treatments for Cannabis Use Disorder across the Lifespan: A Systematic Review. Brain Sci. 2024 Feb 28; 14 (3)
    View PubMed
  4. Oesterle TS, Karpyak VM, Coombes BJ, Athreya AP, Breitinger SA, Correa da Costa S, Dana Gerberi DJ. Systematic review: Wearable remote monitoring to detect nonalcohol/nonnicotine-related substance use disorder symptoms. Am J Addict. 2022 Nov; 31 (6):535-545 Epub 2022 Sept 05
    View PubMed
  5. da Costa SC, Oesterle T, Rummans TA, Richelson E, Gold M. Psychedelic drugs for psychiatric disorders. J Neurol Sci. 2022 Sep 15; 440:120332 Epub 2022 July 05
    View PubMed
  6. Jones G, Suchting R, Zanetti MV, Leung E, da Costa SC, Sousa RT, Busatto G, Soares J, Otaduy MC, Gattaz WF, Machado-Vieira R. Lithium increases cortical and subcortical volumes in subjects with bipolar disorder. Psychiatry Res Neuroimaging. 2022 Aug; 324:111494. Epub 2022 May 21.
    View PubMed
  7. Correa da Costa S, Sanches M, Soares JC. Bipolar Disorder or Borderline Personality Disorder? The challenges in the differential diagnosis of bipolar disorder and borderline personality disorder: Clinical, psychopathological, and sociodemographic correlates Current Psychiatry. 2019; 18(11):27-39.
  8. da Costa SC, Machado-Vieira R, Soares JC. Novel Therapeutics in Bipolar Disorder Current Treatment Options in Psychiatry. 2018; 5(1):162-81.
  9. da Costa SC. Substance Use Disorders In Older Adults: A New Epidemic or an Overlooked Problem? American Academy of Addiction Psychiatry. 2018; 34(1).
  10. Lane SD, da Costa SC, Teixeira AL, Reynolds CF 3rd, Diniz BS. The impact of substance use disorders on clinical outcomes in older-adult psychiatric inpatients. Int J Geriatr Psychiatry. 2018 Feb; 33 (2):e323-e329 Epub 2017 Oct 18
    View PubMed
  11. da Costa SC, Passos IC, Lowri C, Soares JC, Kapczinski F. Refractory bipolar disorder and neuroprogression. Prog Neuropsychopharmacol Biol Psychiatry. 2016 Oct 3; 70:103-10 Epub 2015 Sept 12
    View PubMed
  12. da Costa SC, Passos IC, Reus GZ, Carvalho AF, Soares JC, Quevedo J. The Comorbidity of Bipolar Disorder and Migraine: The Role of Inflammation and Oxidative and Nitrosative Stress. Curr Mol Med. 2016; 16 (2):179-86
    View PubMed
  13. Gazalle FK, Hallal PC, Andreazza AC, Frey BN, Kauer-Sant'Anna M, Weyne F, da Costa SC, Costa SC, Santin A, Kapczinski F. Manic symptoms and quality of life in bipolar disorder. Psychiatry Res. 2007 Sep 30; 153 (1):33-8 Epub 2007 June 04
    View PubMed
  14. Kauer-Sant'Anna M, Tramontina J, Andreazza AC, Cereser K, da Costa S, Costa SC, Santin A, Yatham LN, Kapczinski F. Traumatic life events in bipolar disorder: impact on BDNF levels and psychopathology. Bipolar Disord. 2007 Jun; 9 Suppl 1:128-35
    View PubMed
  15. Kauer-Sant'Anna M, Frey BN, Andreazza AC, Cereser KM, Gazalle FK, Tramontina J, da Costa SC, Costa SC, Santin A, Kapczinski F. Anxiety comorbidity and quality of life in bipolar disorder patients. Can J Psychiatry. 2007 Mar; 52 (3):175-81
    View PubMed
  16. Cereser KM, Frey BN, Bernardes FB, Costa SC, Andreazza AC, Feier G, Souza D, Tramontina F, Goncalves CA, Kapczinski F, Quevedo J. Glial Fibrillary Acidic Protein expression after electroconvulsive therapy in rat brain Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2006; 30(4):663-7.